Cancer ruling benefits cheap drugs in India: Experts 2012-03-15 04:59:05

A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...

Keywords: Thailand, cancer drug Glivec, Nexavar drug, German drug maker Bayer

Read More